Renaissance Technologies
PRNB

Renaissance Technologies’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Renaissance Technologies’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41,700
Closed -$2.49M – 3832
2020
Q2 		$2.49M Sell
41,700
-92,400
-69% -$5.71M ﹤0.01% 2063
2020
Q1 		$7.96M Buy
134,100
+53,700
+67% +$3.13M 0.01% 1302
2019
Q4 		$4.4M Buy
+80,400
New +$3M ﹤0.01% 1928
2019
Q3 		– Sell
-10,900
Closed -$362K – 3844
2019
Q2 		$362K Buy
+10,900
New +$340K ﹤0.01% 3110

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Renaissance Technologies's PRNB Position: Q3 2020 in Review

Renaissance Technologies sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 41,700 shares — an estimated $2.49M sold.

Renaissance Technologies first reported a position in PRNB in Q2 2019 and held it in 4 quarters. The position peaked at $7.96M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Renaissance Technologies reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Renaissance Technologies sold 41,700 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.49M.
  • Renaissance Technologies first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Renaissance Technologies's Principia Biopharma Inc. Common Stock position peaked at $7.96M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.